The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
One-Year Follow-Up Results from AUGMENT-HF: A Multicentre Randomized Controlled Clinical Trial of the Efficacy of Left Ventricular Augmentation with Algisyl in the Treatment of Heart Failure
Open accessAbstract
Aims: AUGMENT-HF was an international, multicentre, prospective, open-label, randomized, controlled evaluation testing the hypothesis that Algisyl (injectable calcium alginate hydrogel) is superior to standard medical therapy (SMT) for improving functional capacity and clinical outcomes in patients with advanced heart failure (HF). We previously reported results following 6 months of follow-up. This report presents the results from 1 year of extended follow up for this clinical trial. Methods and results: We enrolled 78 patients with advanced HF, randomized (1:1), to Algisyl with SMT or SMT alone as previously reported. Patient inclusion criteria were LVEF ≤35%, peak VO2 of 9.0–14.5 mL/min/kg and LV end-diastolic diameter (LVEDD) index 30–40 mm/m2 (LVEDD/body surface area). Patients must have been on stable, evidence-based therapy for HF. A total of 58 patients, mean age 62.3 ± 9.6 years, with ischaemic (57.7%) or non-ischaemic (42.3%) HF completed 12 months of follow-up. Treatment with Algisyl was associated with improved peak VO2 at 12 months; treatment effect vs. control of +2.10 mL/kg/min (95% confidence interval 0.96–3.24, P < 0.001). Statistically significant improvements were observed for VO2 at anaerobic threshold, 6-min walk test distance, and NYHA functional class (all P < 0.001). Through 12 months of follow-up there were 4 (10.5%) deaths in the control group and 9 (22.5%) deaths in the Algisyl group. Conclusions: Algisyl in addition to SMT was more effective than SMT alone for providing sustained 1-year benefits in exercise capacity, symptoms, and clinical status for patients with advanced HF. These data support larger clinical evaluations of this novel therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ingle, L., Shelton, R. J., Rigby, A. S., Nabb, S., Clark, A. L., & Cleland, J. G. F. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi259 · Cited by 126
Cited by
Dilated Cardiomyopathy: Genetic Determinants and Mechanisms
McNally, E. M., & Mestroni, L. (2017) · Circulation Research · doi:10.1161/circresaha.116.309396 · Cited by 786
Metra, M., & Teerlink, J. R. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31071-1 · Cited by 673
Alginate and alginate composites for biomedical applications
Ahmad Raus, R., Wan Nawawi, W. M. F., & Nasaruddin, R. R. (2021) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2020.10.001 · Cited by 627
Traverse, J. H., Henry, T. D., Dib, N., Patel, A. N., Pepine, C., Schaer, G. L., DeQuach, J. A., Kinsey, A. M., Chamberlin, P., & Christman, K. L. (2019) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2019.07.012 · Cited by 306
Cell therapy trials for heart regeneration — lessons learned and future directions
Menasché, P. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0013-0 · Cited by 272
Metadata
- Authors
- Mann, D. L., Lee, R. J., Coats, A. J. S., Neagoe, G., Dragomir, D., Pusineri, E., Piredda, M., Bettari, L., Kirwan, B.-A., Dowling, R., Volterrani, M., Solomon, S. D., Sabbah, H. N., Hinson, A., & Anker, S. D.
- Venue
- European Journal of Heart Failure
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-11-11
- Volume
- 18
- Issue
- 3
- Pages
- 314-325
- ISSN
- 1388-9842 (ISSN-L)
- 1879-0844
- OpenAlex
- W2171423286
- Cited by
- 170
- References
- 1
- FWCI
- 10.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: One-Year Follow-Up Results from AUGMENT-HF: A Multicentre Randomized Controlled Clinical Trial of the Efficacy of Left Ventricular Augmentation with Algisyl in the Treatment of Heart Failure. https://app.cochat.ai/papers/10.1002/ejhf.449
- The paper
- Mann, D. L., Lee, R. J., Coats, A. J. S., Neagoe, G., Dragomir, D., Pusineri, E., Piredda, M., Bettari, L., Kirwan, B.-A., Dowling, R., Volterrani, M., Solomon, S. D., Sabbah, H. N., Hinson, A., & Anker, S. D. (2016). One-Year Follow-Up Results from AUGMENT-HF: A Multicentre Randomized Controlled Clinical Trial of the Efficacy of Left Ventricular Augmentation with Algisyl in the Treatment of Heart Failure. European Journal of Heart Failure. https://doi.org/10.1002/ejhf.449
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.